U.S. Consumer Services Stock News

To the annoyance of some shareholders, Sabre Corporation ( NASDAQ:SABR ) shares are down a considerable 26% in the last...

The Creative Global Technology Holdings Limited ( NASDAQ:CGTL ) share price has softened a substantial 39% over the...

Alliance Entertainment Holding Corporation ( NASDAQ:AENT ) shares have had a horrible month, losing 29% after a...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

1-800-FLOWERS.COM, Inc. ( NASDAQ:FLWS ) shares have retraced a considerable 25% in the last month, reversing a fair...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Elutia Inc. ( NASDAQ:ELUT ) shares have continued their recent momentum with a 28% gain in the last month alone. But...

To the annoyance of some shareholders, Cosmos Health Inc. ( NASDAQ:COSM ) shares are down a considerable 27% in the...

Investors may wish to note that the CEO, President & Director of Sagimet Biosciences Inc. , David Happel, recently...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Why Ridgepost Capital Is On Investors’ Radar Ridgepost Capital (RPC) recently rebranded from P10, Inc. This shift is putting fresh attention on how this multi asset class private market solutions provider is positioned across private equity, venture capital, impact investing, and private credit. See our latest analysis for Ridgepost Capital. At a latest share price of $8.70, Ridgepost Capital has seen a 2.35% 1 day share price return. Its 30 day share price return of 18.77% and 1 year total...

In February 2026, NovoCure announced that the U.S. FDA approved Optune Pax for adult patients with locally advanced pancreatic cancer, to be used alongside gemcitabine and nab-paclitaxel after the Phase 3 PANOVA-3 trial showed a statistically significant overall survival benefit without adding meaningful systemic side effects. This approval marks the first new treatment option for locally advanced pancreatic cancer in decades and further validates NovoCure’s Tumor Treating Fields technology...

On December 31, 2025, FMR LLC reduced its stake in Day One Biopharmaceuticals by 4,380,660 shares, cutting its position by 43.38% but still holding 5,717,008 shares, or 5.60% of the company. This large shift by a major institutional holder may prompt investors to reassess how Day One Biopharmaceuticals fits within broader biotechnology portfolios. Next, we’ll examine how FMR LLC’s sizeable reduction in ownership could influence Day One Biopharmaceuticals’ investment narrative and risk...

Recent performance and business snapshot Tri Pointe Homes (TPH) has drawn investor attention after a series of strong recent returns, including around 27% over the past day, 31% over the past week, and just over 50% in the past 3 months. The homebuilder, headquartered in Incline Village, Nevada, designs, constructs, and sells single family attached and detached homes across the United States. It also offers mortgage financing, title and escrow, and property and casualty insurance agency...

Acadia Realty Trust (AKR) has wrapped up FY 2025 with fourth quarter revenue of US$106.7 million and basic EPS of US$0.04, alongside funds from operations of US$41.6 million, which is a key earnings gauge for REIT investors. The company has seen quarterly revenue move from US$92.8 million in Q4 2024 to US$106.7 million in Q4 2025, while basic EPS shifted from US$0.07 to US$0.04 over the same period. Investors may now weigh the solid top line momentum against margins that are likely to be...

NeoGenomics, NasdaqCM:NEO, has launched PanTracer Pro, a new diagnostic solution for clinicians treating advanced stage solid tumors. The offering combines broad genomic profiling and customized diagnostic testing into a single order with a focus on faster turnaround times. PanTracer Pro is designed to address fragmented testing workflows, treatment delays, and incomplete biomarker assessment in cancer care. NeoGenomics, trading at $11.38, has seen mixed share price performance, with a 30...

NextDecade’s Rio Grande LNG project at the Port of Brownsville continues to progress, with construction activity moving ahead. Peer operator Texas LNG has secured debt financing for a separate LNG facility at the same port, adding another major project to the area. These parallel developments concentrate more LNG infrastructure in Brownsville and could influence how NextDecade positions Rio Grande LNG over time. NextDecade, trading as NasdaqCM:NEXT, is pushing forward with Rio Grande LNG...

StepStone Group (NasdaqGS:STEP) has partnered with Utmost to offer UK clients access to evergreen global private markets strategies. The collaboration focuses on giving a wider range of UK investors exposure to diversified private markets portfolios. The partnership aligns with government-backed efforts in the UK to broaden access to private markets investing. For you as an investor, this move highlights how StepStone Group, a global private markets firm, is positioning its evergreen...

If you are wondering whether Goldman Sachs Group is still attractively priced after its recent run, you are not alone. This article will walk through what the current share price might be implying about value. The stock last closed at US$905.14, with returns of 39.8% over 1 year, 164.8% over 3 years and 223.0% over 5 years. The past month and year to date show declines of 5.9% and 1.0%, and there has been a 2.5% decline over the last week. Recent market attention around large US financial...

Norfolk Southern (NYSE:NSC) has entered into a merger agreement with Union Pacific to form what is described as America's first transcontinental railroad. The transaction comes while Norfolk Southern continues to face legal proceedings related to the 2023 East Palestine incident. These developments are expected to affect the company's operations, regulatory profile, and position within the North American rail industry. For investors watching Norfolk Southern at a share price of $314.94,...

J.M. Smucker (NYSE:SJM) is restructuring its leadership, including removing the Chief Operating Officer role. CEO Mark Smucker is reassuming the President title as part of the new executive setup. Several executives are being promoted, with new roles created to support the company’s transformation plans. The changes include planned retirements and active searches for new leaders in technology and supply chain. J.M. Smucker, the owner of brands across coffee, spreads, snacks and pet food,...

Halozyme Therapeutics (HALO) is drawing attention ahead of its upcoming quarterly earnings report, as analysts project earnings of $2.15 per share and revenue of $448.62 million, with estimates recently revised higher. See our latest analysis for Halozyme Therapeutics. Halozyme Therapeutics’ share price has climbed 11.56% over the past month and 12.99% year to date to US$79.44, while its 1 year total shareholder return of 36.28% suggests momentum has been building over a longer stretch. If...

Smurfit Westrock (NYSE:SW) is back in focus after a busy update cycle, combining fourth quarter earnings, a 5% dividend increase, capacity closures in Quebec, and fresh medium term financial targets through 2030. See our latest analysis for Smurfit Westrock. Those announcements landed alongside a sharp shift in market sentiment, with a 90 day share price return of 52% and a 7 day share price return of 16.81% pushing Smurfit Westrock to US$51.56. The 1 year total shareholder return is slightly...

If you are wondering whether Brookfield Infrastructure Partners units are offering good value right now, this article walks through what the current price could mean for long term investors. The stock last closed at US$38.75, with total returns of 1.9% over 7 days, 10.2% over 30 days, 13.0% year to date and 24.3% over 1 year, compared to 29.5% over 3 years and 37.1% over 5 years. Recent attention on Brookfield Infrastructure Partners has focused on how its listed utilities exposure fits into...